Will immunoglobulin therapy of autoimmune blistering skin diseases survive the new financial management of inpatients?

Späth, Peter J; Hunziker, Thomas (2011). Will immunoglobulin therapy of autoimmune blistering skin diseases survive the new financial management of inpatients? Dermatology, 222(2), pp. 138-9. Basel: Karger 10.1159/000323006

[img]
Preview
Text
000323006.pdf - Published Version
Available under License Publisher holds Copyright.

Download (146kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Späth, Peter Julius, Hunziker, Thomas

ISSN:

1018-8665

Publisher:

Karger

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:18

Last Modified:

21 Jun 2023 11:07

Publisher DOI:

10.1159/000323006

PubMed ID:

21228555

Web of Science ID:

000290094200009

BORIS DOI:

10.48350/5491

URI:

https://boris.unibe.ch/id/eprint/5491 (FactScience: 210238)

Actions (login required)

Edit item Edit item
Provide Feedback